Healio Patients with rheumatoid arthritis being treated with methotrexate or methotrexate with a tumor necrosis factor-alpha inhibitor had significantly reduced seru...
About - News & Issues The FDA has announced that Sandoz is conducting a voluntary nationwide recall of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the U.S. The recall was initiated after particulate matter in vials was discovered ... and more »
4-traders (press release) The Company is developing OTREXUP™, a combination product for the delivery of methotrexate using Medi-Jet™ technology for the treatment of rheumatoid arthritis, poly-articular- course juvenile rheumatoid arthritis and psoriasis, as well as VIBEX™ QS ... and more »
DailyFinance The Company is developing OTREXUP™, a combination product for the delivery of methotrexate using Medi-Jet™ technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis and psoriasis, as well as VIBEX™ QS ...
Healio Researchers studied 31 patients (mean age, 42.2 years; 24 women) with active rheumatoid arthritis (RA; disease duration, less than 5 years) from the IMPRESS trial who randomly were assigned rituximab and methotrexate or placebo and methotrexate .
Healio Patients with moderately active rheumatoid arthritis treated with conventional or reduced doses of etanercept with methotrexate maintained lower disease activity compared with patients treated with methotrexate alone after withdrawal of etanercept ...
Healio Patients with rheumatoid arthritis being treated with methotrexate or methotrexate with a tumor necrosis factor-alpha inhibitor had significantly reduced seru...
Toronto NewsFIX Hair loss also accompanies cancer chemotherapy, commonly with drugs such as methotrexate , cyclophosphamide, and vincristine. Although chemotherapy-associated hair loss is temporary, it can cause a severe loss of self-esteem in the cancer patient.
PharmiWeb.com (press release) ... is well-known and has been used by the medical community for decades; however the linker has broad potential utility with proven affinity to couple with multiple chemotherapeutic agents including paclitaxel docetaxel cisplatin irinotecan and ... and more »
Healio Researchers studied 31 patients (mean age, 42.2 years; 24 women) with active rheumatoid arthritis (RA; disease duration, less than 5 years) from the IMPRESS trial who randomly were assigned rituximab and methotrexate or placebo and methotrexate .
